Close

BIOTECHNOLOGY INDUSTRY REPRESENTATIVE TO TESTIFY ON MEDICARE PRESCRIPTION DRUG BENEFIT

May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Robert Chess, chairman of Inhale Therapeutic Systems, based in San Carlos, Calif., is scheduled to testify on behalf of the Biotechnology Industry Organization ...

BIOLOGIC PRODUCTS SHOULD NOT BE INCLUDED IN USP FOR MEDICARE COVERAGE

May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today released the following statement in response to a Medicare reform press...

Biotechnology CEOs Spread Message On Capitol Hill and Present Legislator of the Year Awards at BIO Legislative Day, May 15-16

May 14 2001
WASHINGTON, D. C. (May 14, 2001) – More than 200 meetings with Capitol Hill legislators are scheduled for biotechnology industry representatives during the Biotechnology Industry Organization’s ...

U.S. Senate Declares May 13-20 National Biotechnology Week

May 11 2001
WASHINGTON, D.C. (May 11, 2001) – The U.S. Senate passed a resolution (attached) declaring May 13 – 20 National Biotechnology Week, thereby recognizing biotechnology’s importance to research and...

BUDGET RESOLUTION GIVES PRESCRIPTION DRUG BENEFIT HOPE

May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today issued the following statement after congressional budget approval of $300 billion...

BIO Endorses Efforts To Ensure High-Quality Patents

May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Lila Feisee, director of government relations and intellectual property at the Biotechnology Industry Organization (BIO), today issued the following statement...

Growth-Enhanced Salmon Offer Nutritional and Environmental Benefits for Consumers

May 9 2001
Statement by Dr. Michael J. Phillips, Executive Director for Food and Agriculture

WASHINGTON, D.C. (May 9, 2001) – “The development of a faster-growing salmon is an important advancement for...

PROPOSED HCFA "NEW TECHNOLOGY" RULE MISSES MARK FOR STREAMLINING MEDICARE DRUG REIMBURSEMENT

May 8 2001
WASHINGTON, D.C. (May 8, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum said today that HCFA’s proposed “New Technology” rule for drug reimbursement is a strong start...

BIO Applauds Codex’s Caution on Labeling

May 4 2001
WASHINGTON, D.C. (May 4, 2001) -Government officials from around the world were in Ottawa this week for the meeting of the Codex Committee on Food Labeling (CCFL), which considered – and tabled –...

MEDIA ADVISORY - LUNCH & BRIEFING

May 3 2001
A CAPITOL HILL LUNCH & BRIEFING:BIOTECHNOLOGY'S IMPACT ON DISEASES OF THE ELDERLY

FRIDAY, MAY 4, 2001 - 562 DIRKSEN SENATE OFFICE BUILDING

WASHINGTON, D.C. (May 3, 2001) - The Biotechnology...